Guía para países de bajos ingresos. 2 edición
Brief instructions for the diagnostic of specimens coming from suspected plague cases and exposed contacts, including recommendations for diagnostic confirmation
2nd edition.
The practical aspects of TB patient care from the onset of symptoms to the completion of treatment are covered in this guide
Decision-makers and frontline responders will find a set of resources on plague here. These resources can be used as refreshers for experienced personnel or as an introduction to the topic for everyone else. Most of the materials are available in English and French, and can be downloaded for offline... use
La version française de ce cours est disponible sur: https://openwho.org/courses/ressources-connaissances-peste
more
Guide pour les pays à faibles revenus.
Open Guidelines is brought to you on behalf of the paediatrics department of Queen Elizabeth
Central Hospital in Blantyre, Malawi. Our aim is to improve access to clinical guidelines for our
health care professionals.
Open guidelines has all the latest QECH clinical protocols and essential drug i...nformation. All
content can be downloaded and afterwards be accessed at any time. The app has a search function.
Total data volume for download is 15 MB. Also on the same app one can access COIN, an excellent neonatal and
infant training course.
more
This is a basic form for reporting individual cases of plague. It asks for information regarding patient history and the course of the illness. In addition, it offers space for laboratory results, the case status, and epidemiological information.
Orientierungshilfe für Ärztinnen und Ärzte
Les décideurs et les intervenants en première ligne trouveront ici les ressources sur la maladie à la peste. Ces ressources peuvent être utilisées en tant que rappels ou compléments de connaissances pour les travailleurs expérimentés ou en tant qu’introduction au sujet pour les autres. La ...plupart des ressources sont disponibles en anglais et en français et peuvent être téléchargées pour un usage sans connexion.
The English version of this course is available at: https://openwho.org/courses/knowledge-resources-plague
more
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...d over 15 million people with lymphoedema. At least 36 million persons remain with these chronic disease manifestations. The disease is endemic in 72 countries. In 2016, an estimated total population of 856 million were living in areas with ongoing transmission of the causative filarial parasites and requiring mass drug administration (MDA). Lymphatic filariasis disfigures and disables, and often leads to stigmatization and poverty. Hundreds of millions of dollars are lost annually due to reduced productivity of affected patients. WHO has ranked the disease as one of the world’s leading causes of permanent and long-term disability.
more
This diagnostic and treatment manual is designed for use by medical professionals involved in cura-
tive care at the dispensary and hospital levels. We have tried to respond in the simplest and most
practical way possible to the questions and problems faced by field medical staff..., using the accumu-
lated field experience of Médecins Sans Frontières, the recommendations of reference organizations
such as the World Health Organization (WHO) and specialized works in each field.
Download as App: https://twitter.com/hashtag/MedicalGuidelines?src=hash
more
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more